BioNexus Gene Lab (BGLC) EPS (2018 - 2026)
BioNexus Gene Lab (BGLC) EPS from Dec 31, 2018 to Mar 31, 2026. The TTM BioNexus Gene Lab (BGLC) EPS is -$1.39. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EPS
Quarterly EPS
BioNexus Gene Lab (BGLC) EPS CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +18.33% |
| 3 Years TTM | +90.44% |
| All Time TTM | +20.39% |
Annual EPS change of BioNexus Gene Lab (BGLC)
| Year | EPS | Change |
|---|---|---|
| 2026 | -$0.22 | -81.88% |
| 2025 | -$1.23 | +38.44% |
| 2024 | -$0.89 | -40.18% |
| 2023 | -$1.49 | +498.60% |
| 2022 | -$0.25 | -147.29% |
| 2021 | $0.53 | -31.19% |
| 2020 | $0.76 | -361.60% |
| 2019 | -$0.29 | -705.36% |
| 2018 | $0.05 | N/A |